Document Detail


Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy.
MedLine Citation:
PMID:  21718818     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
First-line therapy with gefitinib prolongs progression-free survival and improves quality of life among selected patients with non-small cell lung cancer. Selected locally advanced patients may derive benefit from surgical resection after gefitinib therapy. Further clinical trials are needed to evaluate the role of gefitinib therapy followed by surgical resection.
Authors:
Ming Liu; Gening Jiang; Wenxin He; Peng Zhang; Nan Song
Related Documents :
3600008 - Computed tomography for the evaluation of intrathoracic invasion by lung cancer.
11948048 - Mediastinal transthoracic needle and core lymph node biopsy: should it replace mediasti...
21789138 - Treating advanced non-small cell lung cancer in the elderly.
21980258 - Durable remission of inoperable liver metastasis from rectal cancer after hepatic arter...
17484928 - Management of non-retroperitoneal residual germ cell tumor masses.
3180658 - Sequential chemotherapy, surgery and radiotherapy in locally advanced breast cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  92     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-07-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e11-2     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biventricular Continuous Flow VADs Demonstrate Diurnal Flow Variation and Lead to End-Organ Recovery...
Next Document:  Solitary nasopharyngeal metastasis from lung primary: a long-term survivor after radiotherapy.